Characteristics, treatment, and nursing care of patients infected by Sars-CoV-2 hospitalized in intensive care units: multicenter study of colombian hospitals
DOI:
https://doi.org/10.17533/udea.iee.v40n1e08Keywords:
COVID-19, Critical Care, Nursing CareAbstract
Objective. To describe the clinical characteristics, treatment, evolution, and nursing care of adult patients with severe acute respiratory distress syndrome who were positive for SARS-CoV-2 and hospitalized in intensive care units (ICUs) during the first peak of the pandemic in Colombia, 2020.
Methods. Multicenter descriptive study of four high-complexity hospitals in Colombia, which included 473 consecutive adult patients admitted to intensive care units with a confirmed diagnosis of SARS CoV-2. Sociodemographic and clinical information - comorbidities, treatment and evolution - and nursing care provided were included.
Results. Of the patients included, 43.7% died, 88.8% had pneumonia, and 60.2% developed respiratory distress syndrome. Most of those who died were men. Those who died had a median age of 68.4 years and a higher frequency of comorbidities (hypertension, cardiovascular disease, chronic obstructive pulmonary disease, and higher body mass index). They were admitted to the ICU with higher rate of dyspnea, lower oxygen saturation, and higher score of multiorgan failure. They also more often required mechanical ventilation and pronation therapy and were given more vasopressors and renal replacement therapy.
Conclusion. People with severe acute respiratory distress syndrome due to COVID-19 who were hospitalized in the ICU had a high risk of death, especially older patients; males; those with cardiovascular, respiratory, and hypertension comorbidities; those who needed mechanical ventilation; and those with an elevated SOFA score. The nursing care of these critically ill patients focused on respiratory care and the prevention of associated complications.
Downloads
References
1. Organización Mundial de la Salud. Mapa de casos confirmados de COVID-19 de la OMS [Internet]; 2022 [cited 8 Jan 2022]. Available from:https://www.paho.org/es/temas/coronavirus/enfermedad-por-coronavirus-covid-19.
2. Organización Panamericana de la Salud. Brote de enfermedad por el Coronavirus (COVID-19). 2022 [cited 8 Jan 2022] Available from: https://www.paho.org/es/temas/coronavirus/brote-enfermedad-por-coronavirus-covid-19
3. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-62.
4. Reported cases and deaths by country or territory [Internet]. 2022 [Cited 8 Jan 2022]. Available from: https://www.worldometers.info/coronavirus/#countries.
5. Anesi GL. Coronavirus disease 2019 (COVID-19): Critical care issues. Literature review current through: 2020 [cited 7 Apr 2020].
6. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J. Infect. Public Health. 2020; 13(5):667-73.
7. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020; 382(18):1708-20.
8. Wang D, Hu B, Hu Ch, Fang Zhu F, Liu X., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9.
9. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N. Engl. J. Med. 2020; 382(21):2012-22.
10. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum in: JAMA. 2020; 323(20):2098.
11. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-81. Erratum in: JAMA. 2021; 325(20):2120.
12. Centros de Control y Prevención de Enfermedades CDC. Guía clínica provisional para el tratamiento de pacientes con infección confirmada por el nuevo coronavirus 2019 (2019-nCoV) [Internet]; 2020 [12 Feb 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
13. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society. Anaesthesia. 2020; 75(6):785-99.
14. Llamamiento en situación de emergencia por COVID-19 desde la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)y la Sociedad Española de Enfermería Intensiva y Unidades Coronarias (SEEIUC) a los profesionales de cuidados intensivos [Internet]. 2020 [cited 28 Mar 2020]. Available from: http://seeiuc.org/wp-content/uploads/2020/03/Comunicado-conjunto-SEMICYUC-SEEIUC.pdf
15. Sánchez-Oro R, Torres Nuez J, Martínez-Sanz G. Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19). Med. Clin. (Barc). 2020; 155(1):36-40.
16. Intensive Care National Audit and Research Centre (ICNARC). ICNARC report on COVID-19 in critical care. April 24th. London: ICNARC; 2020, page 1-23 [23 Apr 2020]. Available from: https://www.icnarc.org/DataServices/Attachments/Download/c5a62b13-6486-ea11-9125-00505601089b
17. Gao J, Zhong L, Wu M, Ji J, Liu Z, Wang C, Xie Q, Liu Z. Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study. BMC Infect. Dis. 2021; 21(1):602.
18. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020; 94:91-5.
19. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020 23; 15(6):e0234765.
20. Asghari E, Archibald M, Roshangar F. Nursing interventions for patients with COVID-19: A medical record review and nursing interventions classification study. Int. J. Nurs. Knowl. 2022; 33(1):57-63.
21. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N. Engl. J. Med. 2020; 383(19):1813-26.
22. RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021; 397(10285):1637-45.
23. Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg BS, Levin MA, et al. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. J. Am. Coll. Cardiol. 2020; 75(1): 122-4.
24. Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldeota C, Bordell A, et al. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Rev. Esp. Anestesiol. Reanim. (Engl Ed). 2020; 67(8):425-37.
25. Moreira E, Olano E, Manzanares W. Terapia nutricional en el paciente crítico con COVID-19. Una revisión. Rev. Méd. Urug. [Internet]. 2020; 36(4):102-30.
26. Rojas JS, Urriago JD, Montaño YC, Moreno L, Ahumada E, Chavarro GA, et al. Enfoque y manejo clínico de pacientes con enfermedad por SARS cov2 (covid-19) en unidad de cuidado intensivo. Rev. Méd. Sánitas. 2020; 23(1):14-33.
27. Bloomfield R, Noble DW, Sudlow A. Prone position for acute respiratory failure in adults. Cochrane Database Syst. Rev. 2015; (11):CD008095.
28. Team V, Team L, Jones A, Teede H, Weller CD. Pressure Injury Prevention in COVID-19 Patients with Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021; 7:558696.
29. Kamel AHM, Basuoni A, Salem ZA, AbuBakr N. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. Br. Dent. J. 2021 [cited 11 Feb 2021]; Available from: 10.1038/s41415-021-2656-1.
Downloads
Published
Versions
- 2023-09-20 (2)
- 2022-03-28 (1)
How to Cite
Issue
Section
License
Copyright (c) 2022 Investigación y Educación en Enfermería
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos de propiedad / Direitos de Propriedade
English: If the article is accepted for publication, all copyright will be of exclusive property of Investigación y Educación en Enfermería. The text and the graphics included in the publication are exclusive responsibility of the authors and not necessarily reflect the thought of the Editorial Committee.
Español: Si el artículo es aprobado para publicación, todos los derechos son de propiedad de Investigación y Educación en Enfermería. El texto y las gráficas incluidas en la publicación son de exclusiva responsabilidad de los autores y no necesariamente refleja el pensamiento del Comité Editorial.
Português: Se o artigo for aceito para publicação, todos os direitos autorais serão de propriedade exclusiva de Investigación y Educación en Enfermería. O texto e os gráficos incluídos na publicação são de responsabilidade exclusiva dos autores e não refletem necessariamente o pensamento do Comitê Editorial.
